- Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris. Clinical results from the Norwegian randomized trialL Aaberge
Division of Heart and Lung Diseases, The National Hospital, University of Oslo, Norway
J Am Coll Cardiol 35:1170-7. 2000..The purpose of the study was to evaluate clinical effects, exercise performance and effect on maximal oxygen consumption (MVO2) of transmyocardial revascularization with CO2-laser (TMR) in patients with refractory angina pectoris...
- Effects of transmyocardial revascularization on myocardial perfusion and systolic function assessed by nuclear and magnetic resonance imaging methodsL Aaberge
Department of Cardiology, The National Hospital, University of Oslo, Norway
Scand Cardiovasc J 35:8-13. 2001..Whether TMR improves myocardial perfusion or relieves symptoms without altering cardiac function is not clarified...
- Myocardial performance after transmyocardial revascularization with CO(2)laser. A dobutamine stress echocardiographic studyL Aaberge
Department of Cardiology, Division of Heart and Lung Diseases, The National Hospital, University of Oslo, Oslo, Norway
Eur J Echocardiogr 2:187-96. 2001..Transmyocardial laser revascularization is a treatment for patients with severe angina pectoris not eligible for conventional revascularization. The effects on myocardial function and reversible ischaemia have not been clarified...
- Continued symptomatic improvement three to five years after transmyocardial revascularization with CO(2) laser: a late clinical follow-up of the Norwegian Randomized trial with transmyocardial revascularizationLars Aaberge
Department of Cardiology, Rikshospitalet University Hospital, Oslo, Norway
J Am Coll Cardiol 39:1588-93. 2002..The goals of this study were to assess late clinical outcome and left ventricular ejection fraction (LVEF) after transmyocardial revascularization with CO(2) laser (TMR)...
- Cardiac enzymes after transmyocardial laser treatment with CO2 laserO Tjomsland
Feiring Heart Clinic, University of Oslo, Norway
Scand Cardiovasc J 35:19-24. 2001....
- Altered maternal left ventricular contractility and function during normal pregnancyM E Estensen
National Resource Centre for Women s Health, Oslo University Hospital, Rikshospitalet, Oslo, Norway
Ultrasound Obstet Gynecol 41:659-66. 2013..To evaluate maternal left ventricular (LV) systolic and diastolic function during normal pregnancy by non-invasive measures of LV contractility incorporating loading conditions...
- The effect of a neuropeptide Y Y1 receptor antagonist in patients with angina pectorisL Gullestad
Department of Cardiology Rikshospitalet University Hospital, Oslo, Norway
Eur Heart J 24:1120-7. 2003..We examined the effect of a Y1 receptor antagonist on haemodynamic and ischaemic responses to exercise in patients with coronary artery disease...
- Therapeutic hypothermia after out-of-hospital cardiac arrest: experiences with patients treated with percutaneous coronary intervention and cardiogenic shockJ Hovdenes
Department of Anaesthesiology and Intensive Care, Rikshospitalet, Oslo, Norway
Acta Anaesthesiol Scand 51:137-42. 2007..We use therapeutic hypothermia whenever cardiac arrest patients do not wake up immediately after return of spontaneous circulation...
- Different prognostic importance of elevated troponin I after percutaneous coronary intervention in acute coronary syndrome and stable angina pectorisJørgen Gravning
Institute for Surgical Research, Rikshospitalet University Hospital, Oslo, Norway
Scand Cardiovasc J 42:214-21. 2008..To investigate the prognostic importance of cardiac troponin I (cTnI) elevation after percutaneous coronary intervention (PCI) in different clinical settings...